Wednesday, November 15, 2006: 12:30 PM-3:00 PM
California Room (Hilton San Francisco)
#413 - Technology Roadmap: Pharmaceutical Product Development & Manufacturing I (18J01)
The FDA Critical Path Initiative has identified the lack of innovative technology in pharmaceutical product development and manufacture to be a major impediment to reducing time to market as well as cost of drugs. In response to this Initiative, the National Institute for Pharamceutical Technology & Education, a non-for-profit organization, in cooperation with ISPE and the FDA has undertaken development of a Technology Roadmap which identifies specific research needs in these technology domains. In this session two of the main areas of the draft roadmap ( pharmaceutical materials and product development) will be reviewed and feedback sollicited from the ChE research community.
Chair:G. V. Reklaitis
CoChair:Michael Pikal
12:30 PM413aTechnology Roadmap: Context and Drivers for Roadmap Development
Prabir K. Basu
1:00 PM413bTechnology Roadmap: Pharmaceutical Materials Component
Michael Pikal
1:30 PM Panel Discussion
2:00 PM413cTechnology Roadmap: Product Development Component
Lee E. Kirsch
2:30 PM Discussion

See more of Liaison Functions

See more of The 2006 Annual Meeting